Phase II randomized study of trabectedin given as two...

Annals of Oncology 2009 / 11 Vol. 20; Iss. 11

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Del Campo, J. M., Roszak, A., Bidzinski, M., Ciuleanu, T. E., Hogberg, T., Wojtukiewicz, M. Z., Poveda, A., Boman, K., Westermann, A. M., Lebedinsky, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp198
Date:
November, 2009
File:
PDF, 126 KB
english, 2009
Conversion to is in progress
Conversion to is failed